The only non-invasive solution for measuring elevated LVEDP – the clinical hallmark of heart failure.
Vivio is the only FDA-cleared Class II medical device that enables clinicians to non-invasively measure left ventricular end-diastolic pressure (LVEDP) – the clinical hallmark of heart failure. Once Vivio identifies elevated LVEDP, the system prompts the use of the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) to identify patient symptoms and quantify disease burden.
Approximately 70% of patients identified by Vivio with elevated LVEDP exhibit signs and symptoms on the KCCQ-12 consistent with Stage C heart failure while 30% are consistent with Stage B heart failure.1
Delivering real-time, point-of-care results, Vivio helps clinicians identify patients with heart failure earlier and initiate guideline-directed medical therapy (GDMT) in a more timely manner.
Changing the Timeline of Heart Failure Diagnosis
Vivio has superior specificity and sensitivity to clinical indications of heart failure thanks to its ability to identify elevated left ventricle filling pressures (i.e., LVEDP).2,3 This increased sensitivity and specificity allows clinicians to definitively identify patients earlier and with more confidence.
Heart failure is hard to diagnose, and too often, it’s diagnosed too late.
Symptoms progress gradually. Patients may not recognize the warning signs, and clinicians have limited time and tools to detect changes early. As a result, many patients fall through the cracks and are first diagnosed only after their quality of life has already declined when they show up in the ER or are admitted to the hospital.4,5
At Ventric Health, we are closing that gap. We provide clinicians with unprecedented, non-invasive cardiovascular data that enables earlier identification of heart failure, so care teams can act sooner, intervene more effectively and help patients spend more healthy days at home.
That’s why we exist: to expand access to non-invasive cardiovascular testing and be the change that changes heart health.
The path to positively impacting cardiovascular health is through clinicians at the point of care.
Cardiovascular diseases are the leading cause of death in the U.S. and, despite advances in cardiovascular care, the gap in diagnosing the growing risk of heart disease remains.6 In our most vulnerable populations, symptoms are overlooked and diagnostic processes are frequently inconclusive or worse, invasive and costly, leading to poor patient outcomes.4
Precision across care models: the Vivio System enables non-invasive diagnosis of at-risk patients in the primary care setting in the earliest stages of heart failure by identifying elevated left ventricular end-diastolic pressure (LVEDP). Clinicians can perform tests in under five minutes and receive results in real time.
Trusted By Leading Health Systems Across the Country
Expert Perspectives
“Since adopting the Vivio System in March 2024, we’ve been able to identify changes in heart function earlier and initiate treatment sooner. It has become a valued part of our primary care strategy and allows us to have a more engaging connection with our patients while putting the focus on total-person care. Our patients and primary care physicians appreciate the proactive approach.”
“We are proud of the role our technology is playing in practices across the country to make early heart failure diagnosis more accessible, leading to improved patient outcomes and greater clinician satisfaction. Through earlier disease identification, we are helping the healthcare system better control the high and growing costs of heart failure.”
“Our data identified a patient at high risk for heart failure at Dr. DiGennaro’s practice and suggested in-office testing. The resulting positive diagnosis prompted conversations in which the patient revealed previously undisclosed leg swelling. Armed with more and better information, Dr. DiGennaro was able to direct the patient to appropriate medication therapy. Within a month, the patient reported that the leg swelling had resolved, and she was feeling better than she had in a long time.”
“Caring for our senior patients is at the heart of our mission. Because our clinics serve a broad geographic region, bringing the Vivio system directly into our primary care settings allows us to diagnose Heart Failure before patients are expressing symptoms and take action to support treatment without delay. Using Vivio is fast and easy, and having the KCCQ built-in ensures we capture the patient’s symptoms more objectively and consistently.”
